Question 1

What is Eli Lilly (Japan) known for?

Accepted Answer

In research, Eli Lilly (Japan) stands highest in Health Sciences (#9,643 of 16,688 worldwide) and Medicine (#9,029 of 14,558 worldwide), over all time.

Question 2

How does Eli Lilly (Japan) rank in research?

Accepted Answer

Eli Lilly (Japan) ranks #29,013 of 34,923 institutions worldwide on research quality over all time, and #1,230 of 1,923 in Japan.

Question 3

Who are the top researchers at Eli Lilly (Japan)?

Accepted Answer

Ranked on the quality score, Tomonori Oura, Mika Komori and Kaname Ueda lead among researchers whose main affiliation is Eli Lilly (Japan).

Question 4

What are the most cited papers from Eli Lilly (Japan)?

Accepted Answer

The most cited paper from Eli Lilly (Japan) is "Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan" (Takuji Okusaka, Kohei Nakachi, Akira Fukutomi et al., 2010), with 757 citations. Next come "Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial" (619) and "Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor" (373).

Question 5

Which research topics does Eli Lilly (Japan) publish most on?

Accepted Answer

By volume in 2022-now: Diabetes Treatment and Management, Diabetes Management and Research, Migraine and Headache Studies and Diabetes, Cardiovascular Risks, and Lipoproteins.

Question 6

Which keywords describe research at Eli Lilly (Japan)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 2 Diabetes, Obesity, Heart Failure and Clinical Guidelines.

Question 7

Which fields of science does Eli Lilly (Japan) work in?

Accepted Answer

In 2022-now, 84% of research at Eli Lilly (Japan) is in Health Sciences, 11% in Life Sciences. Its largest fields are Medicine (82%), Biochemistry, Genetics and Molecular Biology (5%), Immunology and Microbiology (2%). It does 3.2× the world's share of Health Sciences.

Question 8

Is Eli Lilly (Japan)'s research output growing?

Accepted Answer

Output in 2022-2025 was 10% lower than in 2018-2021.